INMB
INmune Bio Inc.
$1.98
+$0.08(+4.21%)
18
Overall
--
Value
18
Tech
--
Quality
Market Cap
$50.51M
Volume
512.40K
52W Range
$1.71 - $11.64
Target Price
$9.65
Order:
Income Statement
| Metric | Trend | Chart | 2018 Dec | 2019 Dec | 2020 Dec | 2021 Dec | 2022 Dec | 2023 Dec | 2024 Dec |
|---|---|---|---|---|---|---|---|---|---|
| REVENUE | |||||||||
| Total Revenue | -- | -- | $11.0K | $181.0K | $374.0K | $155.0K | $14.0K | ||
| Total Revenue | -- | -- | $11.0K | $181.0K | $374.0K | $155.0K | $14.0K | ||
| GROSS PROFIT | |||||||||
| Gross Profit | -- | -- | $11.0K | $181.0K | $374.0K | $155.0K | $14.0K | ||
| OPERATING EXPENSES | |||||||||
| Operating Expenses | $-12.4M | $7.8M | $12.2M | $29.3M | $26.3M | $29.9M | $42.6M | ||
| Research & Development | $3.4M | $3.3M | $5.9M | $20.5M | $17.1M | $20.3M | $33.2M | ||
| Research Expense | $3.4M | $3.3M | $5.9M | $20.5M | $17.1M | $20.3M | $33.2M | ||
| Selling, General & Administrative | $9.1M | $6.0M | $6.3M | $8.8M | $9.3M | $9.6M | $9.5M | ||
| General & Administrative Expenses | $9.1M | $6.0M | $6.3M | $8.8M | $9.3M | $9.6M | $9.5M | ||
| Salaries & Wages | $-10.0M | $-4.1M | $3.1M | $4.8M | $1.0M | $7.4M | $7.6M | ||
| Other Operating Expenses | -- | $-1.5M | -- | $1.2M | $209.0K | $163.0K | $161.0K | ||
| OPERATING INCOME | |||||||||
| Operating income | $-12.4M | $-7.8M | $-12.2M | $-29.2M | $-26.0M | $-29.7M | $-42.6M | ||
| EBITDA | $-12.4M | $-7.7M | $-12.2M | $-29.2M | $-26.0M | $-34.0M | $-50.1M | ||
| NON-OPERATING ITEMS | |||||||||
| Interest Expense (Non-Operating) | -- | -- | -- | $985.0K | $2.0M | $2.3M | $789.0K | ||
| Intinc | -- | $77.7K | -- | -- | -- | -- | -- | ||
| Net Non-Operating Interest Income/Expense | -- | $77.7K | -- | $-985.0K | $-2.0M | $-2.3M | $-789.0K | ||
| Other Income/Expense | -- | $-77.7K | $-129.0K | $2.0K | $-1.3M | $267.0K | $-553.0K | ||
| Other Special Charges | -- | $77.7K | $129.0K | $-2.0K | $-1.3M | $-267.0K | $553.0K | ||
| PRE-TAX INCOME | |||||||||
| EBIT | $-12.4M | $-7.7M | $-12.2M | $-29.2M | $-26.0M | $-34.0M | $-50.1M | ||
| Pre-Tax Income | $-12.4M | $-7.7M | $-12.1M | $-30.3M | $-27.3M | $-30.0M | $-42.1M | ||
| INCOME TAX | |||||||||
| Tax Provision | $-71.0K | $159.2K | $-2.5M | $-6.4M | $-5.7M | $-6.3M | $-8.8M | ||
| NET INCOME | |||||||||
| Net Income | $-12.4M | $-7.7M | $-12.1M | $-30.3M | $-27.3M | $-30.0M | $-42.1M | ||
| Net Income (Continuing Operations) | $-12.4M | $-7.7M | $-12.1M | $-30.3M | $-27.3M | $-30.0M | $-42.1M | ||
| Net Income (Discontinued Operations) | $-12.4M | $-7.7M | $-12.1M | $-30.3M | $-27.3M | $-30.0M | $-42.1M | ||
| Net Income (Common Stockholders) | $-12.4M | $-7.7M | $-12.1M | $-30.3M | $-27.3M | $-30.0M | $-42.1M | ||
| Normalized Income | -- | -- | -- | $-36.7M | -- | -- | $-50.9M | ||
| TOTALS | |||||||||
| Total Expenses | $-12.4M | $7.8M | $12.2M | $29.3M | $26.3M | $29.9M | $42.6M | ||
| SHARE & EPS DATA | |||||||||
| Average Shares Outstanding | $8.7M | $10.3M | $12.0M | $16.1M | $17.9M | $18.0M | $19.9M | ||
| Average Shares Outstanding (Diluted) | $8.7M | $10.3M | $12.0M | -- | $17.9M | $18.0M | $19.9M | ||
| Shares Outstanding | $26.6M | $10.7M | $14.9M | $17.9M | $17.9M | $26.6M | $26.6M | ||
| Basic EPS | -- | -- | $-1.01 | $-1.88 | $-1.52 | $-1.67 | $-2.11 | ||
| Basic EPS (Continuing Operations) | -- | -- | $-1.01 | $-1.88 | $-1.52 | $-1.67 | $-2.11 | ||
| Diluted EPS | $-1.43 | $-0.75 | $-1.01 | $-1.88 | $-1.52 | $-1.67 | $-2.11 | ||
| Diluted EPS (Continuing Operations) | -- | $-0.75 | -- | -- | $-1.52 | $-1.67 | $-2.11 | ||
| OTHER METRICS | |||||||||
| Other Gand A | $9.1M | $6.0M | $6.3M | $8.8M | $9.3M | $9.6M | $9.5M | ||
| Rent And Landing Fees | $9.1M | -- | -- | -- | -- | -- | -- | ||
Financial data is updated quarterly and may not reflect the most recent earnings.
| A | B | C | D | |
|---|---|---|---|---|
| 1 | Symbol | Price | Change | Vol |
| 2 | INMB | $1.98 | +4.2% | 512.40K |
| 3 | ||||
| 4 | ||||
| 5 | ||||
| 6 |